CAPR — Capricor Therapeutics, Inc. | XLV Holdings | StockAdder

(CAPR)

Capricor Therapeutics, Inc.

Live chart and latest CAPR stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

CAPR News

Capricor Therapeutics (NASDAQ: CAPR) details 2026 meeting, board elections, pay and Deramiocel deals

Apr 10, 2026 Yahoo Finance

Is Capricor Therapeutics (CAPR) Still Attractive After A 72% One Year Share Price Jump

Jan 20, 2026 ChartMill

CAPR Forecast, Price Target & Analyst Ratings | CAPRICOR THERAPEUTICS INC (NASDAQ:CAPR)

Apr 9, 2026 Trefis

Capricor Therapeutics Stock Pre-Market (+12%): 91-Day Insider Lock-Up Period Expires

Mar 7, 2026 Gotrade

Capricor Therapeutics, Inc. Common Stock (CAPR) Stock Price Today & Analysis

Jan 13, 2026 Yahoo Finance

Capricor Therapeutics, Inc. (CAPR): A Bear Case Theory

Dec 18, 2025 Stock Titan

Capricor Therapeutics (CAPR) director sells 7,529 exercised shares

Apr 3, 2026 Yahoo Finance

Capricor Therapeutics (CAPR) Reports Positive Phase 3 HOPE-3 Data and $318M 2025 Cash Balance

Mar 17, 2026 Stock Titan

CAPR SEC Filings - Capricor Therapeutics Inc 10-K, 10-Q, 8-K Forms

Apr 2, 2026 Yahoo Finance

Assessing Capricor Therapeutics (CAPR) Valuation After A Strong Short Term Share Price Run

Mar 10, 2026 Stock Titan

[144] CAPRICOR THERAPEUTICS, INC. SEC Filing

Mar 31, 2026 Yahoo Finance

CAPR Stock Skyrockets 282% in a Week: Here's What You Need to Know

Dec 5, 2025 Stock Titan

FDA resumes review of Duchenne drug Deramiocel, sets Aug. 22 deadline

Mar 10, 2026 Yahoo Finance

Capricor Therapeutics (CAPR) Valuation After FDA Requests HOPE-3 Data For Deramiocel Regulatory Review

Jan 20, 2026 Stock Titan

Capricor (NASDAQ: CAPR) CFO sells 25K shares after option exercise